Wanbang Pharmaceutical: On March 5th, net financing purchase of 645,100 yuan, with a total net purchase of 1,729,200 yuan over the past 3 days.

NightAirdropper · 2026-03-06T20:17:05+00:00

On March 5th, Wanbang Pharmaceutical had a net financing buy-in of 645,100 yuan, with a total net buy-in of 1,729,200 yuan, and the financing balance reached 43,204,300 yuan. On the same day, the net margin sell-off was 0, with a margin loan balance of 5,700 shares, and the combined margin financing and securities lending balance increased to 43,442,200 yuan. The increase in financing indicates that the market is leaning towards the buyers.

NightAirdropper

2026-03-06 20:17:05

Abstract generation in progress

Securities Star News, on March 5th, Wanfang Medicine (301520) had a margin buy-in of 2.9407 million yuan, a margin repayment of 2.2956 million yuan, with a net margin buy-in of 645,100 yuan. The margin balance was 43.2043 million yuan, with a net purchase of 1.7292 million yuan over the past three trading days.

Regarding securities lending, on the same day, 100 shares were lent out, 100 shares were repaid, resulting in a net securities lending sale of 0 shares. The remaining securities lending balance was 5,700 shares.

The total margin and securities lending balance was 43.4422 million yuan, up 1.51% from yesterday.

Quick Facts

Margin Trading and Securities Lending: The margin balance refers to the difference between the amount borrowed to buy stocks and the amount repaid. An increase in margin balance indicates investor optimism, suggesting a strong market; a decrease suggests a weak market. The securities lending balance is the difference between the amount of securities sold and repaid daily. An increase indicates a seller’s market; a decrease indicates a buyer’s market.

The above content is compiled from public information by Securities Star, generated by AI algorithms (Wangxin Algorithm Backup 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes